Benefit vs cost: ASCO unveils cancer drug 'value' tool
This article was originally published in Scrip
Executive Summary
The American Society of Clinical Oncology (ASCO) asked the question "What is a cancer drug's true value?" and in four very specific treatment situations the organization's Value in Cancer Care Task Force supplied an answer: It depends.